Shilpak Chatterjee - Concepedia

Author

Shilpak Chatterjee

Medical University of South Carolina ORCID

Also Known As

Chatterjee, Shilpak, Rajesh Pandey, S Chatterjee, S Vishwapriya, S. Chatterjee, Shilpak Chatterjee, Shilpak Chatterjee (363877), Sucharita Chatterjee

111

Publications

Citations

H-Index

Concepts

All Affiliations

Medical University of South Carolina MUSC Hollings Cancer Center Chittaranjan National Cancer Institute Indian Institute of Chemical Biology Loyola University Chicago

About

Shilpak Chatterjee is an author at Medical University of South Carolina specializing in medicine, immunology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	17	981
2	Cell Biology	11	11	781
3	Biochemistry	3	3	144
4	Engineering	1	1	122
5	Natural Sciences	1	1	11

Shilpak Chatterjee

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
CD38-NAD+Axis Regulates Immunotherapeutic Anti-Tumor T Cell Response Shilpak Chatterjee, Anusara Daenthanasanmak, Paramita Chakraborty, Cell Metabolism Cancer ImmunosurveillanceT-regulatory CellImmunologyTumor ImmunityImmune Regulation	2017	251
Metabolic reprogramming of alloantigen-activated T cells after hematopoietic cell transplantation Hung Nguyen, Shilpak Chatterjee, Kelley M.K. Haarberg, Journal of Clinical Investigation Cell TherapyEngineeringT-regulatory CellImmunologyTransplantation Medicine	2016	122
A Quantitative Increase in Regulatory T Cells Controls Development of Vitiligo Shilpak Chatterjee, Jonathan M. Eby, Amir A. Al-Khami, Journal of Investigative Dermatology Autoimmune DiseaseLymphocyte DevelopmentT-regulatory CellPathogenesisImmunology	2013	108
Nature and Dimensions of Systemic Hyperinflammation and its Attenuation by Convalescent Plasma in Severe COVID-19 Purbita Bandopadhyay, Ranit D’Rozario, Abhishake Lahiri, The Journal of Infectious Diseases	2021	98
Pro-Survival Lipid Sphingosine-1-Phosphate Metabolically Programs T Cells to Limit Anti-tumor Activity Paramita Chakraborty, Silvia G. Vaena, Krishnamurthy Thyagarajan, Cell Reports	2019	95
The role of copper in drug-resistant murine and human tumors Surajit Majumder, Shilpak Chatterjee, Smarajit Pal, BioMetals Oncogenic AgentMedicinePharmacologyPathologyToxicology	2008	85
CCL22 to Activate Treg Migration and Suppress Depigmentation in Vitiligo Jonathan M. Eby, Hee-Kap Kang, Sean T. Tully, Journal of Investigative Dermatology Suppress Depigmentation	2015	76
A novel copper complex induces ROS generation in doxorubicin resistant Ehrlich ascitis carcinoma cells and increases activity of antioxidant enzymes in vital organs in vivo Ananda Mookerjee, Jayati Basu, Surajit Majumder, BMC Cancer	2006	73
Targeting PIM Kinase with PD1 Inhibition Improves Immunotherapeutic Antitumor T-cell Response Shilpak Chatterjee, Paramita Chakraborty, Anusara Daenthanasanmak, Clinical Cancer Research	2018	65
Clinical and immunological benefits of convalescent plasma therapy in severe COVID-19: insights from a single center open label randomised control trial Yogiraj Ray, Shekhar Ranjan Paul, Purbita Bandopadhyay, Viral DiagnosticsImmunodeficienciesPassive ImmunizationImmunologySevere Covid-19 Patients	2020	58

Page 1